Search Results - "Taylor, Jeremy M.G"

Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung by RAPONI, Mitch, YI ZHANG, BEER, David G, YU, Jack, GUOAN CHEN, LEE, Grace, TAYLOR, Jeremy M. G, MACDONALD, James, THOMAS, Dafydd, MOSKALUK, Christopher, YIXIN WANG

“…Non-small-cell lung cancers (NSCLC) compose 80% of all lung carcinomas with squamous cell carcinomas (SCC) and adenocarcinoma representing the majority of…”
Get full text

Gene-expression profiles predict survival of patients with lung adenocarcinoma by Beer, David G, Kardia, Sharon L.R, Huang, Chiang-Ching, Giordano, Thomas J, Levin, Albert M, Misek, David E, Lin, Lin, Chen, Guoan, Gharib, Tarek G, Thomas, Dafydd G, Lizyness, Michelle L, Kuick, Rork, Hayasaka, Satoru, Taylor, Jeremy M.G, Iannettoni, Mark D, Orringer, Mark B, Hanash, Samir

“…Histopathology is insufficient to predict disease progression and clinical outcome in lung adenocarcinoma. Here we show that gene-expression profiles based on…”
Get full text

Subgroup identification from randomized clinical trial data by Foster, Jared C., Taylor, Jeremy M.G., Ruberg, Stephen J.

“…We consider the problem of identifying a subgroup of patients who may have an enhanced treatment effect in a randomized clinical trial, and it is desirable…”
Get full text

Score Test for Conditional Independence Between Longitudinal Outcome and Time to Event Given the Classes in the Joint Latent Class Model by Jacqmin-Gadda, Hélène, Proust-Lima, Cécile, Taylor, Jeremy M.G, Commenges, Daniel

“…Latent class models have been recently developed for the joint analysis of a longitudinal quantitative outcome and a time to event. These models assume that…”
Get full text

Criteria for the use of omics-based predictors in clinical trials by McShane, Lisa M., Cavenagh, Margaret M., Lively, Tracy G., Eberhard, David A., Bigbee, William L., Williams, P. Mickey, Mesirov, Jill P., Polley, Mei-Yin C., Kim, Kelly Y., Tricoli, James V., Taylor, Jeremy M. G., Shuman, Deborah J., Simon, Richard M., Doroshow, James H., Conley, Barbara A.

“…A checklist of criteria to determine the readiness of high-throughput ‘omics’-based tests for guiding patient therapy in clinical trials is discussed; the…”
Get full text

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study by Jacobson, James W, Beer, David G, Shedden, Kerby, Taylor, Jeremy M G, Enkemann, Steven A, Tsao, Ming-Sound, Yeatman, Timothy J, Gerald, William L, Eschrich, Steven, Jurisica, Igor, Giordano, Thomas J, Misek, David E, Chang, Andrew C, Zhu, Chang Qi, Strumpf, Daniel, Hanash, Samir, Shepherd, Frances A, Ding, Keyue, Seymour, Lesley, Naoki, Katsuhiko, Pennell, Nathan, Weir, Barbara, Verhaak, Roel, Ladd-Acosta, Christine, Golub, Todd, Gruidl, Michael, Sharma, Anupama, Szoke, Janos, Zakowski, Maureen, Rusch, Valerie, Kris, Mark, Viale, Agnes, Motoi, Noriko, Travis, William, Conley, Barbara, Seshan, Venkatraman E, Meyerson, Matthew, Kuick, Rork, Dobbin, Kevin K, Lively, Tracy

“…Studies of gene expression in lung cancer have the potential to affect patient care, but the general applicability of the derived classifiers is unclear. David…”
Get full text

Validation of Biomarker-Based Risk Prediction Models by Taylor, Jeremy M G, Ankerst, Donna P, Andridge, Rebecca R

“…The increasing availability and use of predictive models to facilitate informed decision making highlights the need for careful assessment of the validity of…”
Get full text

Interleukin‐6 predicts recurrence and survival among head and neck cancer patients by Duffy, Sonia A., Taylor, Jeremy M.G., Terrell, Jeffrey E., Islam, Mozaffarul, Li, Yun, Fowler, Karen E., Wolf, Gregory T., Teknos, Theodoros N.

“…BACKGROUND. Increased pretreatment serum interleukin (IL)‐6 levels among patients with head and neck squamous cell carcinoma (HNSCC) have been shown to…”
Get full text

EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer by KUMAR, Bhavna, CORDELL, Kitrina G, EISBRUCH, Avraham, TSIEN, Christina I, TAYLOR, Jeremy M. G, D'SILVA, Nisha J, KUN YANG, KURNIT, David M, BAUER, Joshua A, BRADFORD, Carol R, CAREY, Thomas E, LEE, Julia S, WARDEN, Francis P, PRINCE, Mark E, TRAN, Huong H, WOLF, Gregory T, URBA, Susan G, CHEPEHA, Douglas B, TEKNOS, Theodoros N

“…To prospectively identify markers of response to therapy and outcome in an organ-sparing trial for advanced oropharyngeal cancer. Pretreatment biopsies were…”
Get full text

Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo by DaSilva, Alexandre F, Nascimento, Thiago D, Jassar, Hassan, Heffernan, Joseph, Toback, Rebecca L, Lucas, Sarah, DosSantos, Marcos F, Bellile, Emily L, Boonstra, Philip S, Taylor, Jeremy M.G, Casey, Kenneth L, Koeppe, Robert A, Smith, Yolanda R, Zubieta, Jon-Kar

“…OBJECTIVE:To evaluate in vivo the dynamics of endogenous dopamine (DA) neurotransmission during migraine ictus with allodynia. METHODS:We examined 8 episodic…”
Get full text

Confirmation of a Low α/β Ratio for Prostate Cancer Treated by External Beam Radiation Therapy Alone Using a Post-Treatment Repeated-Measures Model for PSA Dynamics by Proust-Lima, Cécile, Ph.D, Taylor, Jeremy M.G., Ph.D, Sécher, Solène, Ph.D, Sandler, Howard, M.D, Kestin, Larry, M.D, Pickles, Tom, M.D, Bae, Kyoungwha, Ph.D, Allison, Roger, F.R.A.N.Z.C.R, Williams, Scott, M.D., F.R.A.N.Z.C.R

“…Purpose To estimate the α/β ratio of prostate cancer treated with external beam radiation only by use of a model of long-term prostate-specific antigen (PSA)…”
Get full text

Semiparametric Modeling of Longitudinal Measurements and Time-to-Event Data-A Two-Stage Regression Calibration Approach by Ye, Wen, Lin, Xihong, Taylor, Jeremy M.G

“…In this article we investigate regression calibration methods to jointly model longitudinal and survival data using a semiparametric longitudinal model and a…”
Get full text

Redefining Perineural Invasion: Integration of Biology With Clinical Outcome by Schmitd, Ligia B., Beesley, Lauren J., Russo, Nickole, Bellile, Emily L., Inglehart, Ronald C., Liu, Min, Romanowicz, Genevieve, Wolf, Gregory T., Taylor, Jeremy M.G., D'Silva, Nisha J.

“…A diagnosis of perineural invasion (PNI), defined as cancer within or surrounding at least 33% of the nerve, leads to selection of aggressive treatment in…”
Get full text

On the detection and refinement of transcription factor binding sites using ChIP-Seq data by Hu, Ming, Yu, Jindan, Taylor, Jeremy M.G, Chinnaiyan, Arul M, Qin, Zhaohui S

“…Coupling chromatin immunoprecipitation (ChIP) with recently developed massively parallel sequencing technologies has enabled genome-wide detection of…”
Get full text

Chemoselection As a Strategy for Organ Preservation in Advanced Oropharynx Cancer: Response and Survival Positively Associated With HPV16 Copy Number by WARDEN, Francis P, KUMAR, Bhavna, PRINCE, Mark E, TSIEN, Christina I, D'SILVA, Nisha J, KUN YANG, KURNIT, David M, MASON, Heidi L, MILLER, Tamara H, WALLACE, Nancy E, BRADFORD, Carol R, CAREY, Thomas E, LEE, Julia S, WOLF, Gregory T, CORDELL, Kitrina G, TAYLOR, Jeremy M. G, URBA, Susan G, EISBRUCH, Avraham, TEKNOS, Theodoros N, CHEPEHA, Douglas B

“…To test induction chemotherapy (IC) followed by concurrent chemoradiotherapy (CRT) or surgery/radiotherapy (RT) for advanced oropharyngeal cancer and to assess…”
Get full text

The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy by Li, Yun, M.S, Taylor, Jeremy M.G., Ph.D, Ten Haken, Randall K., Ph.D, Eisbruch, Avraham, M.D

“…Purpose: A common side effect experienced by head and neck cancer patients after radiation therapy (RT) is impairment of the parotid glands’ ability to produce…”
Get full text

Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials by Li, Yun, Taylor, Jeremy M.G., Elliott, Michael R.

“…A surrogate marker (S) is a variable that can be measured earlier and often more easily than the true endpoint (T) in a clinical trial. Most previous research…”
Get full text

Use of Individual Fraction Size Data from 3756 Patients to Directly Determine the α/β Ratio of Prostate Cancer by Williams, Scott G., F.R.A.N.Z.C.R, Taylor, Jeremy M.G., Ph.D, Liu, Ning, M.S, Tra, Yolande, Ph.D, Duchesne, Gillian M., M.D. F.R.A.N.Z.C.R, Kestin, Larry L., M.D, Martinez, Alvaro, M.D, Pratt, Gary R., F.R.A.N.Z.C.R, Sandler, Howard, M.D

“…Purpose To examine the effect of fraction size and total dose of radiation on recurrence of localized prostate cancer. Methods and Materials A total of 3756…”
Get full text

Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapy by Mason, Heidi, DeRubeis, Mary Beth, Foster, Jared C, Taylor, Jeremy M G, Worden, Francis P

“…To determine whether improved monitoring through close follow-up with a nurse practitioner (NP) could enhance treatment compliance and decrease frequency of…”
Get full text

Discordant Protein and mRNA Expression in Lung Adenocarcinomas by Chen, Guoan, Gharib, Tarek G, Huang, Chiang-Ching, Taylor, Jeremy M G, Misek, David E, Kardia, Sharon L R, Giordano, Thomas J, Iannettoni, Mark D, Orringer, Mark B, Hanash, Samir M, Beer, David G

“…The relationship between gene expression measured at the mRNA level and the corresponding protein level is not well characterized in human cancer. In this…”
Get full text